Improve habits: Focus on protein-rich meals, strength training, and quality sleep to support weight loss
If it freezes, the molecular structure is destroyed, and the medication becomes useless
Due to their weekly dosing schedule and greater mean weight loss seen in trials (15% for semaglutide and 21% for tirzepatide, compared to 8% with liraglutide), semaglutide and tirzepatide are more frequently prescribed than liraglutide for treatment of obesity [33,34,35]
And for all that, I didn't lose weight, and my labs didn't change
Based on todays evidence: Injections produce the highest overall weight loss Oral options offer unmatched convenience with strong early results Both are effective for people with obesity or type 2 diabetes For many patients, the choice is not just which is stronger? But its which is easier to stay on long-term? Side Effects: What the Study Found The clinical trial results for GLP-1 treatments show that orforglipron has a similar side-effect pattern to other GLP-1 receptor agonists: most issues are gastrointestinal and mild to moderate
From kidney health to cognitive function to cardiovascular health, more and more studies are coming out about how far reaching GLP-1s health benefits can be